InDevR Raises $7 million in Series A Financing with Adjuvant Capital
InDevR Raises $7 million in Series A Financing with Adjuvant [...]
InDevR Raises $7 million in Series A Financing with Adjuvant [...]
Clinical validation of the FluChip-8G Influenza A+B Assay for influenza [...]
Analytical Evaluation of the Microarray-Based FluChip-8G Influenza A+B Assay published [...]
ASM Microbe 2019 InDevR will be present at the ASM [...]
510(k) Market Clearance for FluChip-8G Influenza A+B Assay InDevR receives [...]